Physician profile
Amanda Kohl
NPI 1114536844
$874.03
in general payments reported to CMS, 2019-2025
16 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.45 · 2022: $459 · 2023: $146 · 2024: $65.47 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $171.95 | 2022-2025 | Belbuca |
| Medtronic, INC. | $137.71 | 2022 | |
| Saluda Medical Americas, INC. | $95.91 | 2023 | Evoke Scs |
| Indivior INC. | $64.14 | 2024-2025 | Sublocade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.85 | 2022 | |
| Fidia Pharma USA INC. | $52.63 | 2024-2025 | Hymovis |
| Boston Scientific Corporation | $50.96 | 2025 | Intracept |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Abbvie INC. | $33.40 | 2023-2025 | |
| Almatica Pharma LLC | $30.88 | 2022 | |
| Braeburn INC. | $30.05 | 2024-2025 | Brixadi |
| Teva Pharmaceuticals USA, INC. | $29.29 | 2021-2023 | Austedo |
| Amgen INC. | $26.65 | 2021-2022 | |
| Impel Pharmaceuticals INC. | $22.53 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.04 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.04 | 2024 | Emgality, Reyvow |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Kohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.